For healthcare professionals only


Post-marketing surveillance is needed for off licence use of drugs in children

BMJ 2003; 326 doi: (Published 29 March 2003) Cite this as: BMJ 2003;326:712
  1. Michael Tettenborn (, consultant in paediatrics and child health
  1. Frimley Children's Centre, Frimley GU16 7AD

    EDITOR—Sutcliffe's editorial on the issue of testing pharmaceutical products in children addresses a longstanding problem for which there has been much talk but no solution.1 Although not likely to produce the quality of data that would come from formal trials in children, an alternative approach is to develop a …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription